Literature DB >> 3143030

Effects of a Chinese herbal medicine, keishi-bukuryo-gan, on the gonadal system of rats.

S Sakamoto1, H Kudo, T Kawasaki, K Kuwa, N Kasahara, S Sassa, R Okamoto.   

Abstract

Keishi-bukuryo-gan (TJ-25) is a traditional Chinese herbal remedy containing five components: bark of Cinnamomum cassia, root of Paeonia lactiflora, seed of Prunus persica or P. persiba var. davidiana, carpophores of Poria cocos and root bark of Paeonia suffruticosa. This preparation has been used in the treatment of gynecological disorders such as hypermenorrhea, dysmenorrhea and infertility. In the present study, the effects of TJ-25 on plasma levels of luteinizing hormone (LH), follicle-stimulating hormone (FSH) and estradiol (E2), and on uterine wet weight and thymidine kinase (TK) activity were documented in immature rats. Long-term daily oral administration of TJ-25 (300 mg/kg) for 14 days decreased plasma levels of LH, FSH and E2 by 94%, 67% and 50%, respectively, compared to controls. Uterine wet weight and TK activity were reduced to 65% and 64% that of controls, respectively. Short-term effects of TJ-25 on E2 were also examined. Thirty hours after administration of E2 (1.0 micrograms/kg) alone, uterine wet weight and TK activity were elevated 2.4- and 21-fold, respectively, over controls. However, simultaneous administration of TJ-25 (three consecutive doses, every 12 h) with E2 reduced E2-induced increases in uterine wet weight and TK activity by 29% and 39%, respectively. Treatment with TJ-25 also enhanced LH-RH-induced increases in plasma LH and FSH levels 1.2- and 2.5-fold, respectively, as compared with controls. The results obtained in the present study indicate that TJ-25 may act as a LH-RH antagonist and/or as a weak anti-estrogen.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3143030     DOI: 10.1016/0378-8741(88)90002-5

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  5 in total

Review 1.  What has been overlooked on study of Chinese materia medica in the West?

Authors:  Willow J H Liu
Journal:  Chin J Integr Med       Date:  2015-07-09       Impact factor: 1.978

2.  Examination of clinical efficacy of keishibukuryogan on non-specific complaints associated with varicose veins of the lower extremity.

Authors:  Shinobu Hayashi; Shintaro Shibutani; Hirotoki Okubo; Tatsuya Shimogawara; Tsuyoshi Ichinose; Yasuhiro Ito; Kouki Mihara; Tomohisa Egawa; Atsushi Nagashima; Hideaki Obara; Yuko Kitagawa
Journal:  Ann Vasc Dis       Date:  2014-07-30

3.  The Difference between the Two Representative Kampo Formulas for Treating Dysmenorrhea: An Observational Study.

Authors:  Tetsuhiro Yoshino; Kotoe Katayama; Yuko Horiba; Kaori Munakata; Rui Yamaguchi; Seiya Imoto; Satoru Miyano; Hideki Mima; Kenji Watanabe; Masaru Mimura
Journal:  Evid Based Complement Alternat Med       Date:  2016-02-24       Impact factor: 2.629

Review 4.  A Review on the Mechanism and Application of Keishibukuryogan.

Authors:  Koichiro Tanaka; Koki Chiba; Kazuhiko Nara
Journal:  Front Nutr       Date:  2021-12-24

5.  Keishibukuryogan is not carcinogenic in Sprague-Dawley rats.

Authors:  Masanao Kanitani; Nobuo Nishimura; Hiroshi Edamoto; Yoshio Kase
Journal:  J Toxicol Pathol       Date:  2016-02-12       Impact factor: 1.628

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.